Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China
· Delayed Price · Currency is CNY 17.12
+0.37 (2.21%)
May 16, 2025, 3:04 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 1.97 billion as of May 16, 2025. Its market cap has increased by 24.51% in one year.
Market Cap
1.97B
Enterprise Value
3.12B
Revenue
553.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.12
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 1.97B, a decrease of -69.96%. That is a compound annual growth rate of -25.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 1.97B | 6.14% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 342.41B |
| Shenzhen Mindray Bio-Medical Electronics | 273.75B |
| WuXi AppTec | 174.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 126.08B |
| Aier Eye Hospital Group | 118.54B |
| Shanghai United Imaging Healthcare | 113.02B |
| Sichuan Biokin Pharmaceutical | 109.04B |
| Yunnan Baiyao Group Co.,Ltd | 101.22B |